VESOMNI

This brand name is authorized in Austria, Brazil, Croatia, Ireland, Netherlands, Poland, Romania, Spain, UK.

Active ingredients

The drug VESOMNI contains a combination of these active pharmaceutical ingredients (APIs):

1	Solifenacin UNII KKA5DLD701 - SOLIFENACIN SUCCINATE
	Solifenacin is a competitive, specific cholinergic-receptor antagonist. In vitro and in vivo pharmacological studies indicate that solifenacin is a competitive inhibitor of the muscarinic M3 subtype receptor.
	Read more about Solifenacin
2	Tamsulosin UNII 11SV1951MR - TAMSULOSIN HYDROCHLORIDE
	Tamsulosin binds selectively and competitively to post-synaptic α1-adrenoreceptors, prevailingly their subtypes designated α1A and α1D. Thus relaxation of smooth muscles of the prostate and urethra is achieved, which leads to a reduction of tonus and an improvement of the urinary flow.
	Read more about Tamsulosin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VESOMNI Modified release tablets	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G04CA53		G Genito urinary system and sex hormones → G04 Urologicals → G04C Drugs used in benign prostatic hypertrophy → G04CA Alpha-adrenoreceptor antagonists
Discover more medicines within G04CA53

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	540315010002405, 540315010002505
ES	Centro de información online de medicamentos de la AEMPS	78607
GB	Medicines & Healthcare Products Regulatory Agency	236751, 377371, 381737
HR	Agencija za lijekove i medicinske proizvode	HR-H-310582492
IE	Health Products Regulatory Authority	34589, 34594, 34598
NL	Z-Index G-Standaard, PRK	105724
PL	Rejestru Produktów Leczniczych	100327666
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68606001, W68606002, W68606003, W68606004, W68606005, W68606006, W68606007, W68606008, W68606009, W68606010, W68606011